Premium
Biomea Fusion Inc (BMEA)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bi... Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.665 | 41.3043478261 | 1.61 | 2.285 | 1.595 | 901982 | 1.8473602 | CS |
| 4 | -0.225 | -9 | 2.5 | 2.52 | 1.53 | 809657 | 1.91784627 | CS |
| 12 | -2.015 | -46.9696969697 | 4.29 | 4.43 | 1.53 | 652856 | 2.58051834 | CS |
| 26 | -9.055 | -79.920564872 | 11.33 | 12.85 | 1.53 | 753826 | 4.57013575 | CS |
| 52 | -8.725 | -79.3181818182 | 11 | 13.43 | 1.53 | 895030 | 6.15992431 | CS |
| 156 | -0.965 | -29.7839506173 | 3.24 | 43.69 | 1.53 | 698995 | 13.6775007 | CS |
| 260 | -17.725 | -88.625 | 20 | 43.69 | 1.53 | 554586 | 13.53828406 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
